Black Diamond Therapeutics, Inc. (BDTX)

BDTX Statistics

Total Valuation

BDTX has a market cap or net worth of $91.23 million. The enterprise value is $14.84 million.

Market Cap	91.23M
Enterprise Value	14.84M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BDTX has 56.66 million shares outstanding. The number of shares has increased by 25.19% in one year.

Current Share Class	56.66M
Shares Outstanding	56.66M
Shares Change (YoY)	+25.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	2.51%
Owned by Institutions (%)	57.03%
Float	38.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.07
P/TBV Ratio	1.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.92, with a Debt / Equity ratio of 0.27.

Current Ratio	4.92
Quick Ratio	4.79
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.67% and return on invested capital (ROIC) is -38.30%.

Return on Equity (ROE)	-69.67%
Return on Assets (ROA)	-33.71%
Return on Invested Capital (ROIC)	-38.30%
Return on Capital Employed (ROCE)	-74.30%
Revenue Per Employee	n/a
Profits Per Employee	-$2.90M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.86% in the last 52 weeks. The beta is 2.82, so BDTX's price volatility has been higher than the market average.

Beta (5Y)	2.82
52-Week Price Change	-67.86%
50-Day Moving Average	1.75
200-Day Moving Average	3.30
Relative Strength Index (RSI)	52.84
Average Volume (20 Days)	1,288,573

Short Selling Information

The latest short interest is 10.17 million, so 17.96% of the outstanding shares have been sold short.

Short Interest	10.17M
Short Previous Month	7.16M
Short % of Shares Out	17.96%
Short % of Float	26.10%
Short Ratio (days to cover)	1.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-75.84M
Pretax Income	-80.55M
Net Income	-69.68M
EBITDA	-75.49M
EBIT	-75.84M
Earnings Per Share (EPS)	-$1.27

Balance Sheet

The company has $98.58 million in cash and $22.19 million in debt, giving a net cash position of $76.39 million or $1.35 per share.

Cash & Cash Equivalents	98.58M
Total Debt	22.19M
Net Cash	76.39M
Net Cash Per Share	$1.35
Equity (Book Value)	83.29M
Book Value Per Share	1.47
Working Capital	80.60M

Cash Flow

Operating Cash Flow	-62.30M
Capital Expenditures	n/a
Free Cash Flow	-62.30M
FCF Per Share	-$1.10

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BDTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.19%
Shareholder Yield	-25.19%
Earnings Yield	-76.38%
FCF Yield	-68.30%

Analyst Forecast

The average price target for BDTX is $15.60, which is 868.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.60
Price Target Difference	868.94%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1